BNP Paribas Financial Markets Sells 1,778,428 Shares of Tilray Inc (NASDAQ:TLRY)

BNP Paribas Financial Markets trimmed its holdings in Tilray Inc (NASDAQ:TLRY - Free Report) by 97.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,066 shares of the company's stock after selling 1,778,428 shares during the quarter. BNP Paribas Financial Markets' holdings in Tilray were worth $55,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Lido Advisors LLC bought a new position in shares of Tilray in the 4th quarter worth about $28,000. Dudley Capital Management LLC bought a new position in shares of Tilray in the 4th quarter worth about $29,000. Verdence Capital Advisors LLC bought a new position in shares of Tilray in the 4th quarter worth about $29,000. Newman Dignan & Sheerar Inc. increased its stake in shares of Tilray by 61.9% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock worth $35,000 after acquiring an additional 10,000 shares in the last quarter. Finally, Brooklyn FI LLC bought a new position in shares of Tilray in the 4th quarter worth about $36,000. 9.35% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Roth Capital restated a "neutral" rating on shares of Tilray in a research note on Monday, April 14th. Piper Sandler reduced their price objective on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a research note on Wednesday, April 9th.

Tilray Stock Up 2.2%

NASDAQ:TLRY traded up $0.01 on Wednesday, reaching $0.41. 29,778,289 shares of the stock traded hands, compared to its average volume of 28,638,481. The company's fifty day simple moving average is $0.48 and its 200 day simple moving average is $0.87. Tilray Inc has a 12 month low of $0.37 and a 12 month high of $2.15. The company has a market capitalization of $411.76 million, a price-to-earnings ratio of -1.36 and a beta of 1.95. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10.

Tilray (NASDAQ:TLRY - Get Free Report) last announced its quarterly earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The company had revenue of $185.78 million during the quarter, compared to the consensus estimate of $213.38 million. Equities analysts predict that Tilray Inc will post -0.2 EPS for the current fiscal year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.